239 related articles for article (PubMed ID: 29941281)
1. The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management.
Marchegiani G; Andrianello S; Perri G; Pollini T; Caravati A; Secchettin E; Malleo G; Bassi C; Salvia R
Dig Liver Dis; 2018 Dec; 50(12):1327-1333. PubMed ID: 29941281
[TBL] [Abstract][Full Text] [Related]
2. Histopathological evaluation of resected intraductal papillary mucinous neoplasms reveals distinct patterns of invasion in associated carcinomas.
Rift CV; Lund EL; Scheie D; Hansen CP; Hasselby JP
Hum Pathol; 2021 Jul; 113():47-58. PubMed ID: 33915115
[TBL] [Abstract][Full Text] [Related]
3. Management and outcomes of intraductal papillary mucinous neoplasms.
Hipp J; Mohamed S; Pott J; Sick O; Makowiec F; Hopt UT; Fichtner-Feigl S; Wittel UA
BJS Open; 2019 Aug; 3(4):490-499. PubMed ID: 31388641
[TBL] [Abstract][Full Text] [Related]
4. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
[TBL] [Abstract][Full Text] [Related]
5. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of patients with multifocal intraductal papillary mucinous neoplasm following pancreatectomy.
Hashimoto D; Satoi S; Yamamoto T; Yamaki S; Ishida M; Hirooka S; Shibata N; Boku S; Ikeura T; Sekimoto M
Pancreatology; 2022 Nov; 22(7):1046-1053. PubMed ID: 35871123
[TBL] [Abstract][Full Text] [Related]
7. What is the Incidence of Malignancy in Resected Intraductal Papillary Mucinous Neoplasms? An Analysis of Over 100 US Institutions in a Single Year.
Khoury RE; Kabir C; Maker VK; Banulescu M; Wasserman M; Maker AV
Ann Surg Oncol; 2018 Jun; 25(6):1746-1751. PubMed ID: 29560572
[TBL] [Abstract][Full Text] [Related]
8. Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium.
Kerlakian S; Dhar VK; Abbott DE; Kooby DA; Merchant NB; Kim HJ; Martin RC; Scoggins CR; Bentrem DJ; Weber SM; Maithel SK; Ahmad SA; Patel SH
HPB (Oxford); 2019 Apr; 21(4):482-488. PubMed ID: 30361110
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Kuwahara T; Hara K; Mizuno N; Okuno N; Matsumoto S; Obata M; Kurita Y; Koda H; Toriyama K; Onishi S; Ishihara M; Tanaka T; Tajika M; Niwa Y
Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31117111
[TBL] [Abstract][Full Text] [Related]
10. Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series.
Griffin JF; Page AJ; Samaha GJ; Christopher A; Bhaijee F; Pezhouh MK; Peters NA; Hruban RH; He J; Makary MA; Lennon AM; Cameron JL; Wolfgang CL; Weiss MJ
Pancreatology; 2017; 17(3):490-496. PubMed ID: 28416122
[TBL] [Abstract][Full Text] [Related]
11. Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery.
Marchegiani G; Pollini T; Andrianello S; Tomasoni G; Biancotto M; Javed AA; Kinny-Köster B; Amini N; Han Y; Kim H; Kwon W; Kim M; Perri G; He J; Bassi C; Goh BK; Katz MH; Jang JY; Wolfgang C; Salvia R
JAMA Surg; 2021 Jul; 156(7):654-661. PubMed ID: 34009303
[TBL] [Abstract][Full Text] [Related]
12. Intraductal Papillary Mucinous Neoplasms of The Pancreas: A Nationwide Registry-Based Study.
Aronsson L; Andersson B; Andersson R; Tingstedt B; Bratlie SO; Ansari D
Scand J Surg; 2018 Dec; 107(4):302-307. PubMed ID: 29637834
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Management of Main Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Dal Borgo C; Perri G; Borin A; Marchegiani G; Salvia R; Bassi C
Dig Surg; 2019; 36(2):104-110. PubMed ID: 29421807
[TBL] [Abstract][Full Text] [Related]
14. Importance of main pancreatic duct dilatation in IPMN undergoing surveillance.
Marchegiani G; Andrianello S; Morbin G; Secchettin E; D'Onofrio M; De Robertis R; Malleo G; Bassi C; Salvia R
Br J Surg; 2018 Dec; 105(13):1825-1834. PubMed ID: 30106195
[TBL] [Abstract][Full Text] [Related]
15. Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?
Sharib JM; Fonseca AL; Swords DS; Jaradeh K; Bracci PM; Firpo MA; Hatcher S; Scaife CL; Wang H; Kim GE; Mulvihill SJ; Maitra A; Koay EJ; Kirkwood KS
Surgery; 2018 Dec; 164(6):1178-1184. PubMed ID: 30170819
[TBL] [Abstract][Full Text] [Related]
16. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
[TBL] [Abstract][Full Text] [Related]
17. Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN).
Sereni E; Luchini C; Salvia R; Pea A
Chin Clin Oncol; 2019 Apr; 8(2):21. PubMed ID: 31070041
[TBL] [Abstract][Full Text] [Related]
18. An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.
Ohtsuka T; Kono H; Nagayoshi Y; Mori Y; Tsutsumi K; Sadakari Y; Takahata S; Morimatsu K; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
Surgery; 2012 Jan; 151(1):76-83. PubMed ID: 21875733
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Asymptomatic Intraductal Papillary Mucinous Neoplasms in Healthy and Ill Populations Detected by Ultrasonography: A Single-Center Study of 6353 Outpatients.
Ricci C; Migliori M; Imbrogno A; Mazzotta E; Felicani C; Serra C; Bergonzoni B; Calculli L; Casadei R
Pancreas; 2019 Jan; 48(1):113-120. PubMed ID: 30451793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
